Hereditary hemochromatosis (HH) is a highly prevalent genetic disorder characterized by excessive parenchymal iron accumulation leading to liver cirrhosis, diabetes and in some cases hepatocellular carcinoma. HH is caused by mutations in the genes encoding upstream regulators of hepcidin or more rarely in the hepcidin gene itself. A deficit in hepcidin results in intestinal iron hyperabsorption; however, the local effectors mediating the upregulation of iron absorption genes are unknown. We hypothesized that HIF-2 could mediate high iron absorption rates in HH. We generated Hepc -/-mice (a murine model of hemochromatosis) lacking HIF-2 in the intestine and showed that duodenal HIF-2 was essential for the upregulation of genes involved in intestinal iron import and the consequent iron accumulation in the liver and pancreas. This study highlights a role of HIF-2 in the dysregulation of iron absorption and chronic iron accumulation, as observed in patients with hemochromatosis.
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For personal use only. hypoxia. In the presence of oxygen, the HIF-α subunit is hydroxylated by oxygenand iron-dependent prolyl hydroxylases (PHDs) and targeted to the proteasome after the binding to the von Hippel-Lindau (VHL) protein. Upon hypoxia (or iron deficiency), HIF-α is stabilized and binds to the HIF-β constitutive subunit to induce the transcription of target genes 10 .
We hypothesized that HIF-2 could be a mediator of high iron absorption rates in HH and addressed this question by breeding the hepcidin knockout mice (Hepc -/-), a model of severe iron overload, with mice lacking HIF-2 in the intestinal epithelium.
METHODS

Animals
Animal studies described here were reviewed and approved (Agreement n° 
Reverse transcription and real-time quantitative PCR
RNA extraction, reverse transcription, quantitative PCR and sequences of the primers used have been previously described 7 . All samples were normalized to the threshold cycle value for cyclophilin.
Western blot
Frozen whole duodenal tissue was homogenized using a pestle and smash and extraction of membrane proteins was performed as previously described 7 . The following antibodies were used : DMT1 antibody recognizing both DMT1-IRE and non-IRE isoforms 12 (kind gift of François Cannone-Hergaux), DCYTB antibody (Alpha Diagnostic DCYTB11-A), FPN antibody (Alpha Diagnostic, MTP11-A).
Iron measurements and Immunostaining
Plasma and tissue iron were quantified colorimetrically by a previously described method 7 . For histology, tissues were fixed in 4% formaldehyde and embedded in paraffin and stained with Perls' Prussian blue and nuclear fast red counter stain.
Statistical analysis
Analysis was performed using GraphPad Prism 4.0 and the significance of For
RESULTS AND DISCUSSION
To test whether HIF-2 can mediate the upregulation of iron absorption genes in HH, we generated Hepc -/-mice deleted for HIF-2α in the duodenum (Hepc -/-
HIF-2α
Δint mice). These mice do not exhibit any overt phenotypic abnormalities. We previously reported that DMT1, DCYTB and FPN protein levels were increased in the duodenum of hepcidin deficient mice (the Usf2 -/-mouse model 13 ). We confirmed this result ( Figure 1B ) and further demonstrated that Hepc -/-mice presented high levels of DMT1, DCYTB and FPN mRNA (although to a lesser extent) in comparison to control mice ( Figure 1A ) suggesting that a transcriptional control of these genes takes place in the duodenum of these mice. The levels of DMT1, DCYTB and FPN transcript and protein, were fully attenuated in Hepc -/-HIF-2α Δint ( Figure 1A, B) compared to Hepc -/-mice with levels not statistically different of wild type mice. The duodenal deletion of HIF-2α decreased significantly FPN protein levels, despite the lack of hepcidin, which should prevent FPN degradation by systemic regulation.
We next asked whether the decrease of genes involved in iron absorption at the apical (DMT1 and DCYTB) and the basolateral membrane (FPN) was sufficient to prevent the hyperabsorption characteristic of the Hepc -/-mice. Interestingly, the double knockout presented a significantly decreased accumulation of non-heme iron in the liver and pancreas as compared to Hepc -/-littermates. This was assessed both quantitatively ( Figure 2A ) and qualitatively by Perls' blue staining ( Figure 2B ).
Plasma ferritin levels, reflecting parenchymal iron storage, were significantly diminished in Hepc -/-mice lacking duodenal HIF-2, compared to Hepc -/-mice ( Figure   2C ). However, plasma iron concentrations or transferrin saturation ( Figure 2C ) did figure) .
Altogether, our data suggest that HIF-2 contributes to the intestinal iron hyperabsorption in a mouse model of HH but may not overcome all of the negative consequences of the abnormal iron metabolism. Associations between SNPs at HIF-2α locus and blood-related phenotypes have been recently demonstrated 15, 16 . It would be of interest to determine whether HIF-2α polymorphisms could be found associated with iron burden in hemochromatosis. Current treatments for iron overload disorders are limited to phlebotomy or, in case of severe anemia, cardiac failure, or poor tolerance, to chelation therapies 2 . Here, we propose that therapeutical intervention on intestinal HIF-2α activity might be beneficial to reduce the rates of iron absorption and parenchymal iron overload.
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